CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 200 target
Drug / intervention
Outpatient Treatment of Pulmonary Embolismother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02355548
NCT02355548N/ACompleted

Rapid Risk Stratification for Outpatient Treatment of Low-risk Pulmonary Embolism

Intermountain Health Care, Inc.·observational·Posted Feb 4, 2015·Updated Nov 29, 2018

In Brief

An observational study evaluating Outpatient Treatment of Pulmonary Embolism for Pulmonary Embolism. Completed, enrolled 200 participants across 1 site.

Detailed Summary

This study is looking at the safety and effectiveness of treating Patients diagnosed with a low-risk Pulmonary Embolism (PE) in an outpatient setting instead of the standard, in-patient hospitalization. Patients have several medical tests done during their Emergency Department visit. Based on those tests, those who are determined to have a low-risk PE are eligible to participate in the study. Those choosing to participate are discharged after 12 hours of medical observation. Patients who choose to participate are followed up by telephone approximately 90 days later.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
20132014201520162017201820192020202120222023202420252026
First PostedFeb 4, 2015
Enrollment StartDec 1, 2012
Primary CompletionDec 1, 2017
TodayJul 2, 2026
Enrollment to primary: 5 yearsPosted 11.4 years ago

Interventions

Outpatient Treatment of Pulmonary Embolismother

Patients who participate in the study will be treated for their pulmonary embolism in an outpatient setting instead of being hospitalized.